Avandia and Heart Attacks
A team of class action and personal injury lawyers has launched an investigation into Avandia (also known as "Rosiglitazone"), the type 2 Diabetes drug sold by GlaxoSmithKline, which has been linked to increased risk of heart attacks and heart related deaths. In a recent study, researchers found that the risk of a heart attack was increased 43 percent among those taking Avandia and that there was a 64 percent increased risk of dying from cardiovascular causes while taking the drug.
If you or your loved ones have ever taken Avandia, and have had a heart attack or related death potentially associated with the use of Avandia, you may be entitled to money.**
**If you have used Avandia and suffer from any of the side effects, we also urge you to promptly consult your doctor for an evaluation.
Fill out the form on the right for a free
attorney review.